BigDeal cover image

The Case for Ozempic, Weed’s Risks, and Big Pharma Conspiracies | Mike Israetel

BigDeal

CHAPTER

Rethinking Corporate Health Responsibilities

This chapter examines the changing perspectives on drug and food companies, particularly after vaccine rollouts and rising obesity rates. It argues for the potential of these corporations to prioritize health and wellness over profit motives, while also addressing consumer responsibility in health decisions. The discussion further critiques the notion of pharmaceutical greed and promotes a collaborative, long-term approach to corporate practices that benefit society.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner